Tomoyuki Koga

University of Minnesota

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (14)

Yang Li

Assistant Professor

Washington University in St. Louis

UNITED STATES

View details

Sihan Wu

Assistant Professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

Ming Li

Assistant Prof.

University of Minnesota

UNITED STATES

View details

Jun Ma

University of Minnesota

UNITED STATES

View details

shunya hanakita

Saitama Medical University

JAPAN

View details

David Gutmann

Donald O. Schnuck Family Professor

Washington University

UNITED STATES

View details

Yoshitaka Narita

Head

National Cancer Center Hospital

JAPAN

View details

Kazuhiro Tsuchiya

Visiting Professor

Kyorin University

JAPAN

View details

Cathy Barr

Professor

University of Toronto

CANADA

View details

Lukas Chavez

Assistant Professor

University of California, San Diego

UNITED STATES

View details

Frank Furnari

Professor and Co-Director, Sanford Stem Cell Institute Brain Tumor Program

University of California, San Diego

UNITED STATES

View details

Logan Spector

University of Minnesota

UNITED STATES

View details

R. Stephanie Huang

University of Minnesota

UNITED STATES

View details

Yoshiki Arakawa

Professor and Chair

Kyoto University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tomoyuki Koga

Research Interests

Explore related searches

Contact this professor

Articles (14)

Stem cell modeling of nervous system tumors

Integration of Computational Pipeline to Streamline Efficacious Drug Nomination and Biomarker Discovery in Glioblastoma

Integrated analysis of single-cell chromatin state and transcriptome identified common vulnerability despite glioblastoma heterogeneity.

Randomized phase III study of high-dose methotrexate and whole-brain radiotherapy with/without temozolomide for newly diagnosed primary CNS lymphoma: JCOG1114C

Pioneering models of pediatric brain tumors

Age-Dependent Hemorrhage Risk and Obliteration Benefit After Radiosurgery for Brain Arteriovenous Malformation

Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies

TERT promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening in vivo

Structural studies of SALL family protein zinc finger cluster domains in complex with DNA reveal preferential binding to an AATA tetranucleotide motif

High Dose Radiosurgery Targeting the Primary Tumor Sites Contributes to Survival in Patients With Skull Base Chordoma.

Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug

PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response

PTEN deficiency leads to proteasome addiction: a novel vulnerability in glioblastoma.

SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stability.

Collaborators (14)

Yang Li

Sihan Wu

Ming Li

Jun Ma

shunya hanakita

David Gutmann

Yoshitaka Narita

Kazuhiro Tsuchiya

Cathy Barr

Lukas Chavez

Frank Furnari

Logan Spector

R. Stephanie Huang

Yoshiki Arakawa

Make your next move.